Samsung Medical Center: all 1,005 studies
Page 6 of 11. Open to participants first (148), then studies with results posted, then the rest; newest registration first within each.
- Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer PatientsStatus unknownNCT03053856Phase 2
- Study of Vismodegib in Advanced Gastric Adenocarcinoma Patients With SMO OverexpressionCompletedNCT03052478Phase 2
- A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKIStatus unknownNCT03050437Phase 2
- The Effect of a Walking Assist Robot on Gait Function and Brain Activity in Stroke Patients and Elderly AdultsCompletedNCT03048968Not applicable
- Assessment of Kidney Function for Drug Dosage Adjustments in Critically Ill PatientsStatus unknownNCT03045692Not applicable
- Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFRActive, not recruitingNCT03030495
- Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A MutationsCompletedNCT03009682Phase 2
- Research on Quantification of VR(Virtual Reality) Related Stress and RelaxationStatus unknownNCT02986555Not applicable
- A 6-month Post-interventional Follow-up Extension of VOLUME Study (VOLUME-2)CompletedNCT02986412Not applicable
- Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid NeuroimagingStatus unknownNCT02983838
- Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast CancerStatus unknownNCT02967146Phase 3
- BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian CancerCompletedNCT02963688
- Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic CancerStatus unknownNCT02934984
- Long-term Prognosis of Cluster Headache: a Retrospective Cohort StudyStatus unknownNCT02895256
- Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)Active, not recruitingNCT02890953Phase 2
- Driving Pressure and Postoperative Pulmonary ComplicationsCompletedNCT02851238Not applicable
- Transperitoneal vs Retroperitoneal Laparoscopic or Robotic Partial NephrectomyStatus unknownNCT02849119Not applicable
- Optimal Treatment Strategy Based on for Pediatric AMLStatus unknownNCT02848183Phase 2
- Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor BiomarkerCompletedNCT02848066
- Gait Pattern Analysis and Feasibility of Gait Training With a Walking Assist Robot in Stroke Patients and Elderly AdultsCompletedNCT02843828Not applicable
- Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markersStatus unknownNCT02815176
- The Usefulness of Ultrasound Guided Technique Insertion of Radial Artery Catheter in Neonates and InfantsCompletedNCT02795468Not applicable
- Pegteograstim in Children With Solid TumorsStatus unknownNCT02787876Phase 2
- Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell TumorStatus unknownNCT02784054Phase 2
- Response Based Treatment for Children With Unresectable Localized Soft Tissue SarcomaStatus unknownNCT02784015Phase 2
- Chemotherapy Plus Reduced Radiotherapy in Intracranial GerminomaStatus unknownNCT02782754Phase 2
- Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast CancerStatus unknownNCT02781259Phase 4
- Response-based Treatment of High-risk NeuroblastomaStatus unknownNCT02771743Phase 2
- Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in StrokeCompletedNCT02768571Phase 4
- Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem CellCompletedNCT02755376Not applicable
- Effect of Pravastatin in the Subjects With Prediabetes or Early DiabetesCompletedNCT02754739Phase 4
- Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or GefitinibCompletedNCT02747953Phase 2
- Isoniazid Dosage Prediction Model DevelopmentStatus unknownNCT02747654Not applicable
- Anticoagulation in Cancer Related StrokeStatus unknownNCT02743052
- Superb Microvascular Imaging in Focal Nodular HyperplasiaCompletedNCT02737865Not applicable
- The Impact of Early Protocol Biopsy in Kidney TransplantStatus unknownNCT02733510
- Rotational Atherectomy for Calcified lEsion By Smart Angioplasty Research Team (SMART-RACE)Status unknownNCT02716363Not applicable
- FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel DiseaseCompletedNCT02715518Not applicable
- Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid TumorsCompletedNCT02691793Phase 4
- Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid TumorsWithdrawnNCT02691780Not applicable
- Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid TumorsCompletedNCT02691767Not applicable
- Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry StudyCompletedNCT02691351
- The Development of Skin Adhesive Patches for the Monitoring and Prediction of Mental DisordersStatus unknownNCT02690324Not applicable
- A Study on the Changes of the Biological Rhythm by Display Image ModulationCompletedNCT02690311Not applicable
- Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 MutationTerminatedNCT02688907Phase 2
- Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid TumorsCompletedNCT02688881Phase 4
- The Lamina Cribrosa (LC) Changes in the Eyes After Laser-Assisted in Situ Keratomileusis (LASIK)CompletedNCT02676557
- Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular HemorrhageStatus unknownNCT02673788
- Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell LymphomaCompletedNCT02670616Phase 2
- A Trial of Evonail® Solution for Prevention or Treatment of OnycholysisCompletedNCT02670603Not applicable
- MR-based Collateral Imaging to Predict Response to Endovascular Treatment of Stroke (FAST-COLL Study)Status unknownNCT02668627
- The Effect of Steroid Pulse Therapy for the Reduction of Acute Rejection Episode in Subclinical Borderline ChangesStatus unknownNCT02664493Not applicable
- Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open LaparotomyCompletedNCT02653469
- Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic CancerStatus unknownNCT02646228
- Colonoscopy-related Pain Predicts the Treatment Response of Amitriptyline in Patients With Irritable Bowel SyndromeStatus unknownNCT02638870
- Genomics-Based Target Therapy for Children With Relapsed or Refractory MalignancyStatus unknownNCT02638428Phase 2
- Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II TrialStatus unknownNCT02632864Phase 2
- Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory CancerCompletedNCT02630199Phase 1
- Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma With Integrative Genomic AnalysisCompletedNCT02628951Phase 2
- A Study of Pembrolizumab for Patients With Thymic Epithelial TumorCompletedNCT02607631Phase 2
- EValuation of the Impact of a TOpical Lotion on Permanent Chemotherapy Induced Hair Disorders in Cancer SurvivorsCompletedNCT02605629Not applicable
- REal World Advanced Experience of BioResorbable ScaffolD by SMart Angioplasty Research Team (SMART REWARD)Status unknownNCT02601404
- The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer PatientsStatus unknownNCT02599012Phase 2
- Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast CancerStatus unknownNCT02597179
- Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.CompletedNCT02593591
- Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.Status unknownNCT02593578
- Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer PatientsCompletedNCT02593019Phase 2
- A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBCStatus unknownNCT02592746Phase 2
- Genetic Alteration After Systemic Treatment in Breast CancerStatus unknownNCT02591966
- Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown PrimaryStatus unknownNCT02590055Phase 2
- Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective StudyStatus unknownNCT02588781Phase 2
- Use of Transexamic Acid in Hip ReplacementStatus unknownNCT02587845Phase 3
- Myocardial Flow Reserve in Severe AS Without Obstructive Coronary Artery DiseaseCompletedNCT02575768
- Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisCompletedNCT02571946Not applicable
- Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and NeckStatus unknownNCT02558387Phase 2
- Prospective Registration of Head and Neck CancerCompletedNCT02546895
- A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR PathwayCompletedNCT02544997Phase 2
- VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)Status unknownNCT02544425Phase 2
- Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial CarcinomaStatus unknownNCT02535650Phase 2
- Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux DiseaseStatus unknownNCT02533349Phase 3
- A New Track Ablation Device for Liver Biopsy: A Feasibility StudyStatus unknownNCT02521129Phase 1/2
- Adjuvant Durvalumab for Esophageal CancerStatus unknownNCT02520453Phase 2
- The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic DiseaseStatus unknownNCT02516826Phase 2
- Thoracic Epidural for Postoperative IleusCompletedNCT02491385Not applicable
- EAA/Therapy for Treating Children With ADHDStatus unknownNCT02482649Not applicable
- Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.CompletedNCT02468375Phase 4
- Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib TherapyStatus unknownNCT02461849Phase 2
- Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative PainCompletedNCT02461056Not applicable
- Stroke Volume Variation and Pulse Pressure Variation as Predictors of Fluid Responsiveness During Kidney TransplantationCompletedNCT02459470Not applicable
- Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial AtherosclerosisStatus unknownNCT02458755Phase 4
- Pulse Pressure Variation Measured During Valsalva Maneuver to Predict Fluid Responsiveness Under Open-chest ConditionCompletedNCT02457572
- Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line ChemotherapyCompletedNCT02451956Phase 2
- Lateral Rectus Muscle and Anterior Segment Optical Coherence Tomography (AS-OCT) in Two Recession SurgeriesStatus unknownNCT02450162
- Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid TumorsCompletedNCT02450149Not applicable
- Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid TumorsCompletedNCT02450136Not applicable
- Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid TumorsCompletedNCT02450123Not applicable
- Trial of AZD5363 Plus Paclitaxel /AZD2014 Plus Paclitaxel in Biomarker Negative (PIK3CA/MEK/RAS/TP53/MET) Gastric Adenocarcinoma Patients as Second-line ChemotherapyTerminatedNCT02449655Phase 2
- The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid TumorsCompletedNCT02449564Not applicable
- Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line TreatmentCompletedNCT02449551Phase 2
- Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid TumorsCompletedNCT02449538Phase 2